Le Lézard
Classified in: Health
Subjects: LGB, AVO, DEI

ASDSA Alerts Nation's Governors to New Trend in Anti-transgender Legislation


ROLLING MEADOWS, Ill., April 14, 2021 /PRNewswire-PRWeb/ -- The American Society for Dermatologic Surgery Association (ASDSA) has sent a letter to all 50 state governors along with legislative leaders, alerting them to the increase in anti-transgender legislation that is proliferating in state legislatures across the country. After Arkansas became the first state to ban gender affirming care for transgender youth, ASDSA felt the need to voice its concern, as procedural dermatology is an important aspect of gender affirmation treatment.

Although some of the bills moving through state legislatures seek to protect the transgender community, many of them are similar to the new law in Arkansas. "This type of legislation takes away physician and patient autonomy to choose treatment options, emboldens other states to pass similar laws and does permanent damage to the gender diverse population since we know lack of access to quality health care is directly linked to the high rate of suicide in this population," said ASDSA President Mathew Avram, MD, JD.

Mona Gohara, MD, chair of the ASDS Diversity, Equity and Inclusion (DEI) Work Group, echoed these concerns, stating "It is the opinion of organized medicine that denying gender affirming care to transgender people can cause devastating, life-changing outcomes and mental health crises, which could result in suicide. Governors must do everything they can to protect their transgender citizens, which includes vetoing any of these dangerous and medically unfounded bills that come across their desk."

In November 2020, the ASDS / ASDSA Board of Directors approved the organization's DEI position statement, which includes pledging to support policies that ensure nondiscrimination and are sensitive to the health and well-being of Lesbian, Gay, Bisexual, Transgender and Queer (LGBTQ) / Sexual and Gender Minority (SGM) individuals and enhance the health of LGBTQ / SGM people.

ASDSA will continue to monitor state legislation that impacts the health of the LGBTQ / SGM population and how dermatologic surgeons and their patients may be impacted. Visit http://asds.net/diversity to learn more about ASDS / ASDSA's diversity initiatives.

About ASDSA
With a membership of 6,400+ physicians, ASDSA is a 501(c) (6) association, dedicated to education and advocacy on behalf of dermatologic surgeons and their patients. For more information, visit http://asds.net/ASDSA.

Follow @ASDSAdvocacy on Facebook, Twitter, Instagram and LinkedIn!

Media Contact

Kristin Hellquist, American Society for Dermatologic Surgery Association, 847-956-9144, [email protected]

Twitter, Facebook

 

SOURCE American Society for Dermatologic Surgery Association


These press releases may also interest you

at 02:05
AstraZeneca: Revenue and EPS summary     Q1 2024 % Change $m Actual CER1 - Product Sales 12,177 15 18 - Alliance Revenue   457 59 59...

at 02:00
Indivior PLC (LSE/Nasdaq: INDV) today announced its financial results for the period ending March 31, 2024. The earnings release, investor presentation and webcast are available at www.indivior.com. The earnings release can be found at...

at 02:00
In response to the increasing complexities of the aging journey and the rising trend of...

at 02:00
PRISM BioLab, Co. Ltd. ("PRISM"), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction (PPI) targets, today announced that it has entered into a target-exclusive research and...

at 02:00
Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood...

at 01:24
Sedana Medical AB (publ) announces that all 235 randomized patients have been recruited for its INSPiRE-ICU 1 phase III clinical trial in the United States. Concurrently, the identical INSPiRE-ICU 2 trial is nearing completion, with 23 of 235...



News published on and distributed by: